Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 7;6(6):CD011751.
doi: 10.1002/14651858.CD011751.pub3.

Interventions for smoking cessation in people diagnosed with lung cancer

Linmiao Zeng  1 , Xiaolian Yu, Tingting Yu, Jianhong Xiao, Yushan Huang
Affiliations

Interventions for smoking cessation in people diagnosed with lung cancer

Linmiao Zeng et al. Cochrane Database Syst Rev. .

Abstract

Background: Lung cancer is one of the most common causes of death from cancer worldwide. Smoking induces and aggravates many health problems, including vascular diseases, respiratory illnesses and cancers. Tobacco smoking constitutes the most important risk factor for lung cancer. Most people with lung cancer are still active smokers at diagnosis or frequently relapse after smoking cessation. Quitting smoking is the most effective way for smokers to reduce the risk of premature death and disability. People with lung cancer may benefit from stopping smoking. Whether smoking cessation interventions are effective for people with lung cancer and whether one method of quitting is more effective than any other has not been systematically reviewed.

Objectives: To determine the effectiveness of smoking cessation programmes for people with lung cancer.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (accessed via PubMed) and Embase up to 22 December 2018. We also searched the American Society of Clinical Oncology (ASCO) Annual Meeting proceedings, the lung cancer sections of the proceedings of the ESMO Congress, the lung cancer sections of the proceedings of the European Conference of Clinical Oncology (ECCO) Congress, the World Conference on Lung Cancer proceedings, the Society for Research on Nicotine and Tobacco Annual Meeting from 2013, the Food and Drug Administration website, the European Medicine Agency for drug registration website, the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal, ClinicalTrials.gov, and the metaRegister of Controlled Trials (mRCT) to 30 December 2018. We applied no restriction on language of publication.

Selection criteria: We planned to include any randomised controlled trial (RCT) of any psychosocial or pharmacological smoking cessation intervention or combinations of both, compared with no intervention, a different psychosocial or pharmacological (or both) intervention or placebo for pharmacological interventions in people with lung cancer.

Data collection and analysis: Two review authors independently screened the studies from the initial search for potential trials for inclusion. We planned to use standard methodological procedures expected by Cochrane. We found no trials that met the inclusion criteria.

Main results: We identified no RCTs that met our inclusion criteria. Among the 1817 records retrieved using our search strategy, we retrieved 19 studies for further investigation. We excluded 15 trials: ten trials because we could not distinguish people with lung cancer from the other participants, or the participants were not people with lung cancer, four because they were not randomised, or RCTs. We excluded one trial because, though it was completed in 2004, no results are available. We assessed four ongoing trials for inclusion when data become available.

Authors' conclusions: There were no RCTs that determined the effectiveness of any type of smoking cessation programme for people with lung cancer. There was insufficient evidence to determine whether smoking cessation interventions are effective for people with lung cancer and whether one programme is more effective than any other. People with lung cancer should be encouraged to quit smoking and offered smoking cessation interventions. However, due to the lack of RCTs, the efficacy of smoking cessation interventions for people with lung cancer cannot be evaluated and concluded. This systematic review identified a need for RCTs to explore these.

PubMed Disclaimer

Conflict of interest statement

Linmiao Zeng: none known

Xiaolian Yu: none known

Tingting Yu: none known

Jianhong Xiao: none known

Yushan Huang: none known

Figures

1
1
Study flow diagram.
See this image and copyright information in PMC

Update of

References

References to studies excluded from this review

Bastian 2011 {published data only}
    1. Bastian LA, Fish LJ, Peterson BL, Biddle AK, Garst J, Lyna P, et al. Proactive recruitment of cancer patients' social networks into a smoking cessation trial. Contemporary Clinical Trials 2011;32(4):498‐504. [DOI: 10.1016/j.cct.2011.03.006] - DOI - PMC - PubMed
Bastian 2013 {published data only}
    1. Bastian LA, Fish LJ, Peterson BL, Biddle AK, Garst J, Lyna P, et al. Assessment of the impact of adjunctive proactive telephone counseling to promote smoking cessation among lung cancer patients' social networks. American Journal of Health Promotion 2013;27(3):181‐90. [DOI: 10.4278/ajhp.101122-QUAN-387] - DOI - PubMed
Browning 2000 {published data only}
    1. Browning KK, Ahijevych KL, Ross P Jr, Wewers ME. Implementing the Agency for Health Care Policy and Research's Smoking Cessation Guideline in a lung cancer surgery clinic. Oncology Nursing Forum 2000;27(8):1248‐54. - PubMed
Clavero 2014 {published data only}
    1. Clavero JM, Silva‐Illanes N, Itriago LI, Gil R, Seijas D. Design, implementation and preliminary results of a tobacco cessation program in a private clinic [Abstract]. Journal of Thoracic Oncology 2014;9 Suppl 3:S160‐1.
NCT00032084 {published data only}
    1. NCT00032084. S0002 ‐ a program to quit smoking with or without bupropion in treating patients with stage I or II non‐small cell lung cancer who have undergone surgery. clinicaltrials.gov/ct2/show/NCT00032084 (accessed 15 July 2015).
NCT01457469 {published data only}
    1. NCT01457469. Enhanced Quitline intervention in smoking cessation for patients with non‐metastatic lung cancer. clinicaltrials.gov/ct2/show/NCT01457469 (accessed 15 July 2015).
Price 2017 {published data only}
    1. Price S, Hitsman B, Veluz‐Wilkins A, Blazekovic S, Brubaker TR, Leone F, et al. The use of varenicline to treat nicotine dependence among patients with cancer. Psychooncology 2017;26(10):1526‐34. - PMC - PubMed
Rettig 2018 {published data only}
    1. Rettig EM, Fakhry C, Hales RK, Kisuule F, Quon H, Kiess AP, et al. Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy. Head & Neck 2018;40(7):1534‐47. - PMC - PubMed
Schnoll 2003 {published data only}
    1. Schnoll RA, Zhang B, Rue M, Krook JE, Spears WT, Marcus AC, et al. Brief physician‐initiated quit‐smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. Journal of Clinical Oncology 2003;21(2):355‐65. - PubMed
Schnoll 2004a {published data only}
    1. Schnoll RA, Rothman RL, Newman H, Lerman C, Miller SM, Movsas B, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology 2004;13(5):346‐58. - PubMed
Schnoll 2004b {published data only}
    1. Schnoll RA, Rothman RL, Lerman C, Miller SM, Newman H, Movsas B, et al. Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment. Head & Neck 2004;26(3):278‐86. - PubMed
Spangler 2015 {published data only}
    1. Spangler J, Weaver KE, Case D, Lesser G, Burton G, Dy IA, et al. Feasibility of using memantine in smoking cessation among cancer survivors. Journal of Clinical Oncology 2015;33(SUPPL. 1):15.
Weaver 2015a {published data only}
    1. Weaver K, Kaplan S, Urbanic J, Case D, Zbikowski S, Dakhil CSR, et al. Incorporating evidence‐based smoking cessation into community oncology practices: feasibility and preliminary efficacy of an enhanced quitline‐based smoking cessation intervention for cancer survivors. Psycho‐Oncology 2015;24(Suppl. 2):32.
Weaver 2015b {published data only}
    1. Weaver KE, Urbanic JJ, Case D, Kaplan SG, Lesser GJ, Zbikowski S, et al. Preliminary efficacy of an enhanced quitline smoking cessation intervention for cancer patients. Journal of Clinical Oncology 2015;15(SUPPL. 1):33.
Wewers 1997 {published data only}
    1. Wewers ME, Jenkins L, Mignery T. A nurse‐managed smoking cessation intervention during diagnostic testing for lung cancer. Oncology Nursing Society 1997;24(8):1419‐22. - PubMed

References to ongoing studies

NCT01192256 {published data only}
    1. NCT01192256. Studies examining the importance of smoking after being diagnosed with lung cancer. clinicaltrials.gov/ct2/show/NCT01192256 (accessed 15 July 2015).
NCT01434342 {published data only}
    1. NCT01434342. Feasibility of delivering a Quitline based smoking cessation intervention in cancer patients. clinicaltrials.gov/ct2/show/NCT01434342 (accessed 15 July 2015).
NCT02048917 {published data only}
    1. NCT02048917. Smoking cessation strategies in community cancer programs for lung and head and neck cancer patients. clinicaltrials.gov/ct2/show/NCT02048917 (accessed 15 July 2015).
NCT02856581 {published data only}
    1. NCT02856581. Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes. https://clinicaltrials.gov/ct2/show/NCT02856581 (accessed 18 March, 2019).

Additional references

ACCP 2013
    1. Leone FT, Evers‐Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest 2013;143(5 Suppl):e61S‐77S. - PubMed
Alberg 2013
    1. Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest 2013;143(5 Suppl):e1S‐29S. - PMC - PubMed
Andreas 2007
    1. Andreas S, Herth FJ, Rittmeyer A, Kyriss T, Raupach T. Smoking, chronic obstructive pulmonary disease and lung cancer. Pneumologie 2007;61(9):590‐4. - PubMed
Andreas 2013
    1. Andreas S, Rittmeyer A, Hinterthaner M, Huber RM. Smoking cessation in lung cancer‐achievable and effective. Deutsches Ärzteblatt International 2013;110(43):719‐24. - PMC - PubMed
Balduyck 2011
    1. Balduyck B, Sardari Nia P, Cogen A, Dockx Y, Lauwers P, Hendriks J, et al. The effect of smoking cessation on quality of life after lung cancer surgery. European Journal of Cardio‐thoracic Surgery 2011;40(6):1432‐7. - PubMed
Baser 2006
    1. Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Lin E, et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 2006;130(6):1784‐90. - PubMed
Brambilla 2001
    1. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. European Respiratory Journal 2001;18(6):1059‐68. - PubMed
Cahill 2012
    1. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD006103.pub6] - DOI - PubMed
Cahill 2013
    1. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta‐analysis. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD009329.pub2] - DOI - PMC - PubMed
Cataldo 2010
    1. Cataldo JK, Dubey S, Prochaska JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010;78(5‐6):289‐301. - PMC - PubMed
Chen 2012
    1. Chen J, Qi Y, Wampfler JA, Jatoi A, Garces YI, Busta AJ. Effect of cigarette smoking on quality of life in small cell lung cancer patients. European Journal of Cancer 2012;48(11):1593‐601. - PMC - PubMed
Coleman 2012
    1. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi‐Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010078] - DOI - PubMed
De Groot 2012
    1. Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiologic Clinics of North America 2012;50(5):863‐76. - PubMed
Eng 2014
    1. Eng L, Su J, Qiu X, Palepu PR, Hon H, Fadhel E, et al. Second‐hand smoke as a predictor of smoking cessation among lung cancer survivors. Journal of Clinical Oncology 2014;32(6):564‐70. - PubMed
ESMO Guidelines Working Group 2014
    1. Reck M, Popat S, Reinmuth N, Ruysscher D, Kerr KM, Peters S. Metastatic non‐small‐cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Annals of Oncology 2014;25(Suppl 3):iii27‐39. - PubMed
Ettinger 2012
    1. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, et al. Non‐small cell lung cancer. Journal of the National Comprehensive Cancer Network 2012;10(10):1236‐71. - PubMed
Ettinger 2013
    1. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, et al. Non‐small cell lung cancer, version 2. 2013. Journal of the National Comprehensive Cancer Network 2013;11(6):645‐53; quiz 653. - PubMed
Garces 2004
    1. Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, Ebbert JO, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 2004;126(6):1733‐41. - PubMed
Goldstraw 2007
    1. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami‐Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. Journal of Thoracic Oncology 2007;2(8):706‐14. - PubMed
Hartmann‐Boyce 2014
    1. Hartmann‐Boyce J, Lancaster T, Stead LF. Print‐based self‐help interventions for smoking cessation. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD001118.pub3] - DOI - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.com.
Hughes 2000
    1. Hughes JR, Stead LF, Lancaster T. Anxiolytics for smoking cessation. Cochrane Database of Systematic Reviews 2000, Issue 4. [DOI: 10.1002/14651858.CD002849] - DOI - PMC - PubMed
Hughes 2007
    1. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine & Tobacco Research 2007;9(3):315‐27. - PubMed
Hughes 2014
    1. Hughes JR, Stead LF, Hartmann‐Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4] - DOI - PMC - PubMed
Hurt 2011
    1. Hurt RD, Ebbert JO, Hays JT, McFadden DD. Preventing lung cancer by treating tobacco dependence. Clinics in Chest Medicine 2011;32(4):645‐57. - PubMed
Lancaster 2005
    1. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001292.pub2] - DOI - PubMed
Land 2012
    1. Land SR. Methodologic barriers to addressing critical questions about tobacco and cancer prognosis. Journal of Clinical Oncology 2012;30(17):2030‐2. - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009;62(10):e1‐34. - PubMed
Morissette 2007
    1. Morissette SB, Tull MT, Gulliver SB, Kamholz BW, Zimering RT. Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychological Bulletin 2007;133(2):245‐72. - PubMed
National Cancer Institute
    1. National Cancer Institute. SEER stat fact sheets: lung and bronchus cancer. seer.cancer.gov/statfacts/html/lungb.html (accessed 14 June 2015).
Nayan 2013
    1. Nayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta‐analysis. Otolaryngology‐Head and Neck Surgery 2013;149(2):200‐11. - PubMed
Park 2012
    1. Park ER, Japuntich SJ, Rigotti NA, Traeger L, He Y, Wallace RB, et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer 2012;118(12):3153‐64. - PMC - PubMed
Parsons 2010
    1. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta‐analysis. BMJ 2010;21(340):b5569. - PMC - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rice 2013
    1. Rice VH, Hartmann‐Boyce J, Stead LF. Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD001188.pub4] - DOI - PubMed
Rigotti 2012
    1. Rigotti NA, Clair C, Munafò MR Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD001837.pub3] - DOI - PMC - PubMed
Stead 2005
    1. Stead L, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001007.pub2] - DOI - PubMed
Stead 2012
    1. Stead LF, Perera R, Bullen C, Mant D, Hartmann‐Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD000146.pub4] - DOI - PubMed
Stead 2013a
    1. Stead LF, Hartmann‐Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD002850.pub3] - DOI - PubMed
Stead 2013b
    1. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann‐Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD000165.pub4] - DOI - PMC - PubMed
Tobacco Use and Dependence Guideline Panel 2008
    1. Tobacco Use, Dependence Guideline Panel. Treating tobacco use and dependence: 2008 update. Washington, DC: US Department of Health and Human Services, 2008.
Vaidya 2014
    1. Vaidya V, Hufstader‐Gabriel M, Gangan N, Shah S, Bechtol R. Utilization of smoking‐cessation pharmacotherapy among chronic obstructive pulmonary disease (COPD) and lung cancer patients. Current Medical Research and Opinion 2014; Vol. 30, issue 6:1043‐50. [DOI: 10.1185/03007995.2014.884493] - DOI - PubMed
Videtic 2003
    1. Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited‐stage small‐cell lung cancer is associated with decreased survival. Journal of Clinical Oncology 2003;21(8):1544‐9. - PubMed
Walker 2006
    1. Walker MS, Vidrine DJ, Gritz ER, Larsen RJ, Yan Y, Govindan R, et al. Smoking relapse during the first year after treatment for early‐stage non‐small‐cell lung cancer. Cancer Epidemiology, Biomarkers & Prevention 2006;15(12):2370‐7. - PubMed

References to other published versions of this review

Zeng 2015
    1. Zeng L, Yu X, Yu T, Xiao J, Huang Y. Interventions for smoking cessation in people diagnosed withlung cancer. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD011751.pub2] - DOI - PubMed

Publication types